Cambridge Cognition Holdings plc COG
Dividend Summary
There have not been any declared dividends recently.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | – | – |
| Type | – | – |
| Per share | – | – |
| Declaration date | – | – |
| Ex-div date | – | – |
| Pay date | – | – |
Enter the number of Cambridge Cognition Holdings plc shares you hold and we'll calculate your dividend payments:
Sign up for Cambridge Cognition Holdings plc and we'll email you the dividend information when they declare.
Add Cambridge Cognition Holdings plc to receive free notifications when they declare their dividends.
Your account is set up to receive Cambridge Cognition Holdings plc notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| There are no Cambridge Cognition Holdings plc dividends. | ||||||||
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0p | — |
| 2007 | 0.0p | 0% |
| 2008 | 0.0p | 0% |
| 2009 | 0.0p | 0% |
| 2010 | 0.0p | 0% |
| 2011 | 0.0p | 0% |
| 2012 | 0.0p | 0% |
| 2013 | 0.0p | 0% |
| 2014 | 0.0p | 0% |
| 2015 | 0.0p | 0% |
| 2016 | 0.0p | 0% |
| 2017 | 0.0p | 0% |
| 2018 | 0.0p | 0% |
| 2019 | 0.0p | 0% |
| 2020 | 0.0p | 0% |
| 2021 | 0.0p | 0% |
| 2022 | 0.0p | 0% |
| 2023 | 0.0p | 0% |
| 2024 | 0.0p | 0% |
| 2025 | Sign Up Required | |
Cambridge Cognition Holdings plc Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 09 July 2024
- 52 Week Low
- 0.0% on 09 July 2024
- Next Ex-Div-Date Countdown
- Sign Up Required
About Cambridge Cognition Holdings plc
Cambridge Cognition Holdings plc is a neuroscience technology company. The Company develops and markets digital solutions to assess brain health for sale worldwide, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight and NeuroVocalix. Its services include neuroscience consultancy, study design, data analysis, study management, data management plan, reporting and interpretation and technical consultancy. Its CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas. Its Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone applications for high frequency data collection to demonstrate treatment efficacy and increase the understanding of a disease and a patient's response to medication.
- Sector
- Software & Computer Services
- Country
- United Kingdom
- Share Price
- £0.33 (yesterday's closing price)
- Shares in Issue
- 42 million
- Market Cap
- £14mn
- 0
- Market Indices
- none
